Wat is de prijs voor Novartis AG (NVS)

Het prijs van Novartis AG (NVS) is $150.75

Wat is de marktkapitalisatie voor Novartis AG (NVS)

Marktkapitalisatie voorNovartis AG (NVS) is $291.41B

Novartis AG (NVS) Uitstaande Aandelen

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Jaar	Uitstaande aandelen	Wijzigen
Niet genoeg gegevens voor de verstrekte datums.

Jaar

Uitstaande aandelen

Wijzigen

Niet genoeg gegevens voor de verstrekte datums.

Bedrijf	Uitstaande aandelen	Verschil	Land
Eli Lilly LLY.US	898.00M	-	US
AstraZeneca PLC AZN.US	3.10B	-	GB
Johnson & Johnson JNJ.US	2.43B	-	US
AbbVie Inc. ABBV.US	1.78B	-	US
Merck & Co., Inc. MRK.US	2.49B	-	US

Bedrijf

Uitstaande aandelen

Verschil

Land